F
1652
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Fusen Pharmaceutical Co Ltd has significantly outperformed Hang Seng (Hong Kong), delivering a return of +281% compared to the Hang Seng (Hong Kong)'s +6% growth.
Stocks Performance
1652 vs Hang Seng (Hong Kong)
Performance Gap
1652 vs Hang Seng (Hong Kong)
Performance By Year
1652 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Fusen Pharmaceutical Co Ltd
Glance View
Fusen Pharmaceutical Co., Ltd. manufactures pharmaceuticals and medical devices. The company is headquartered in Nanyang, Henan. The company went IPO on 2018-07-11. The firm is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The firm's main products include small volume injections, oral liquids, tablets, capsules and granules. The firm distributes its products mainly in domestic market.
